Neurogene (NGNE) FCF Margin: 2019-2025
Historic FCF Margin for Neurogene (NGNE) over the last 3 years, with Sep 2025 value amounting to 46,750.00%.
- Neurogene's FCF Margin fell 3610263.00% to 46,750.00% in Q3 2025 from the same period last year, while for Sep 2025 it was 12,852.46%, marking a year-over-year increase of 680122.00%. This contributed to the annual value of -7,720.11% for FY2024, which is 19251654.00% down from last year.
- Per Neurogene's latest filing, its FCF Margin stood at 46,750.00% for Q3 2025, which was up 76.65% from 26,464.86% recorded in Q2 2025.
- In the past 5 years, Neurogene's FCF Margin registered a high of 454,300.00% during Q1 2023, and its lowest value of 3,044.47% during Q2 2024.
- Moreover, its 3-year median value for FCF Margin was 46,750.00% (2025), whereas its average is 115,923.69%.
- Its FCF Margin has fluctuated over the past 5 years, first slumped by 45,067,193bps in 2024, then skyrocketed by 2,342,040bps in 2025.
- Over the past 3 years, Neurogene's FCF Margin (Quarterly) stood at 100,294.12% in 2023, then crashed by 9,604,267bps to 4,251.45% in 2024, then slumped by 3,610,263bps to 46,750.00% in 2025.
- Its FCF Margin stands at 46,750.00% for Q3 2025, versus 26,464.86% for Q2 2025 and 26,975.00% for Q1 2025.